DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 125 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,422 | +5.2% | 599 | +7.9% | 0.00% | – |
| Q4 2023 | $8,953 | -14.4% | 555 | -32.5% | 0.00% | – |
| Q3 2023 | $10,456 | +22.8% | 822 | +35.9% | 0.00% | – |
| Q2 2023 | $8,518 | -8.9% | 605 | 0.0% | 0.00% | – |
| Q1 2023 | $9,347 | -27.8% | 605 | -23.4% | 0.00% | – |
| Q4 2022 | $12,948 | +1194.8% | 790 | +1419.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 52 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 52 | +126.1% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 23 | +53.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 15 | -21.1% | 0.00% | – |
| Q4 2019 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |